Title: Pierre Attali: Innovator in Mucoadhesive Buccal Tablets
Introduction
Pierre Attali is a notable inventor based in France. He has made significant contributions to the field of pharmaceutical innovations, particularly in the treatment of orofacial herpes. His work focuses on developing effective delivery systems for antiviral agents.
Latest Patents
Pierre Attali holds a patent for "Mucoadhesive Buccal Tablets For The Treatment Of Orofacial Herpes." This invention relates to the treatment and/or prevention of muco-cutaneous herpes simplex virus diseases using prolonged release mucoadhesive buccal tablets. These tablets comprise an acyclic guanosine antiviral agent and are particularly suitable for the treatment and/or prevention of orofacial herpes. He currently has 0 patents.
Career Highlights
Throughout his career, Pierre Attali has worked with various companies, including LNHc, Inc. and Epi Health, LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Pierre has collaborated with Dominique Costantini, enhancing his research and development efforts in the field.
Conclusion
Pierre Attali is a dedicated inventor whose work in mucoadhesive buccal tablets showcases his commitment to advancing treatments for orofacial herpes. His contributions to the pharmaceutical industry are noteworthy and reflect his innovative spirit.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.